Chemistry

Marie Curie was a Polish-French physicist and chemist who conducted pioneering research on radioactivity. Not only was she the first woman to win a Nobel Prize and the only person to win a Nobel Prize in two different sciences, she was the first person and only woman to win twice! Her outstanding achievements include the development...

This week, the LabRoots team is taking a trip to Atlanta, Georgia for the Pittcon 2016 conference. We are joining the global exposition, which gives the opportunity for attendees to learn about the  latest in laboratory instrumentation, watch live demos and seminars, talk with technical experts, and discover solutions to laboratory challenges. LabRoots is excited...

Welcome to the New Year! For LabRoots, the New Year brings the launch of our new Trending newsletter by category! Beginning in January, the Trending newsletter will get a face-lift. Our general Trending newsletter will still be coming to you two days per week. In order to offer you added information and news on the...

LabRoots just got back from attending the Clinical Expo at AACC2015 in Atlanta. What a success! The American Association of Clinical Chemistry organized a wonderful conference this year, with fantastic speakers and a convention center full of companies showcasing new products and innovative technologies. We enjoyed learning about the new technologies brought to the Clinical...

LabRoots will be exhibiting at the annual American Association for Clinical Chemistry meeting in Atlanta July 26-30. We are always excited to join the other great companies at this meeting and be a part of bringing very informative and cutting edge information to attendees. The AACC 2015 meeting is a leading event for laboratory medicine worldwide....

Researchers have found that a protein vital for cell health that has recently been associated with cancer and diabetes, can juggle its cellular to-do list—in effect having two alike protein parts split the workload. A key protein for most life forms—the TH enzyme (transhydrogenase)—works inside mitochondria. “Despite its importance, TH has been one of the least-studied mitochondrial...

Can a new use for an established drug make an even greater impact than the current one? Some researchers in Israel think so. Scientists at Ben Gurion University of the Negev (BGU) in Beershaba, Israel, have found that the anti-inflammatory drug alpha-1 antitrypsin (AAT), now used to treat type 1 diabetes and various inflammatory problems, may...

With drug companies investing huge amounts of time and money to produce viable products, it is not surprising that they look for drug candidates that will provide a return on the investment.  Whereas rare diseases may not have been the way to go before, there are indications that the trend may be changing in some...

An investigational cholesterol-reducing drug lowered patients’ levels of bad cholesterol by about 62 percent after six months, and halved their risk of premature death, stroke, and heart attack versus a placebo, researchers report. The drug, calledalirocumab, was developed by Sanofi, Paris, and Regeneron Pharmaceuticals Inc, Tarrytown, NY. The companies are encouraged by the findings, but say...

An emerging street drug that is up to 15 times more potent than heroin—sold to users as heroin—is looming on the horizon, according to an article in the journal in Annals of Emergency Medicine. The quasi-legal drug, called acetyl fentanyl, is an opiate that is brewed into street drugs. Users generally inject it intravenously. The drug...